Skip to main content
Explore URMC


Featured Speakers

Snell Memorial Lecturer, Reza Dana, M.D., M.Sc., M.P.H.

Reza Dana, MD, MSc, MPH is the Claus Dohlman Professor of Ophthalmology at Harvard University and Massachusetts Eye and Ear Institute. There he is director for the Cornea and Refractive Surgery Center, Vice Chair for Academic Programs and a Senior Scientist at the Schepens Eye Research Institute. Dana is one the world’s most prolific cornea researchers and has been honored numerous times for his insights. This includes the Stein Innovation Award and the Friedenwald Award. As an ophthalmologist and immunologist, his principal research interests is in determining the molecular and cellular regulation of corneal and ocular surface immunity. His laboratory focuses on the role of cytokines and chemokines in the induction of antigen-specific corneal immunity, activation of antigen-presenting cells, and the interface of hemangiogenesis and lymphangiogenesis in inflammation. Other areas of active research include the dysfunction of regulatory T cells in autoimmunity,and dry eye disease, and high-risk corneal transplantation.

Dana has authored hundreds of journal articles and is a prolific presenter at scientific and clinical meetings. A Harvard Medical School Clifford Barger Excellence in Mentoring Award recipient, he has focused extensively on teaching both clinical and basic researchers and has served as primary mentor to more than 110 laboratory trainees from 32 countries, as well as more than 75 clinical fellows. A strong advocate for clinical scientists in bridging the wide gap between basic science and clinical applications, he directs the Harvard-Vision Clinical Scientist Development Program.

Frederick Dushay, MD, Distinguished Visiting Professor, David Huang, M.D., Ph.D.

David Huang, MD, PhD, is the Peterson Professor of Ophthalmology and a Professor of Ophthalmology and Biomedical Engineering at the Oregon Health & Science University (OHSU).  He earned his medical degree from Harvard University and a PhD in Medical Engineering and Medical Physics from Massachusetts Institute of Technology.   He received ophthalmology residency training at the Doheny Eye Institute/University of Southern California and completed fellowship training in cornea, external disease and refractive surgery at Emory University School of Medicine.  Prior to joining OHSU, Dr. Huang had been on the faculty of the Cleveland Clinic and the University of Southern California.

Huang is known for his innovations in applying laser and optical technology to eye diseases.  He is a co-inventor of optical coherence tomography (OCT.  More recently he pioneered anterior segment OCT and OCT angiography.  His seminal article on optical coherence tomography, published in Science in 1991, has been cited more than 13,000 times.  He has 21 issued patents in the areas of OCT, mobile health testing, tissue engineering and corneal laser surgery.  He has been the principal investigator of five National Institutes of Health research grants totaling over $20 million.   He has published more than 250 peer-reviewed articles with over 40,000 citations, and edited 10 books.  Huang has received the Champalimaud Vision Award, the largest prize given for ophthalmic research, the Jonas Friedenwald Award, one of the highest awards from the Association for Research in Vision & Ophthalmology, the Fritz J and Dolores H. Russ Prize - given by the National Academy of Engineering for outstanding bioengineering achievment that improves the human condition, and the Senior Achievement Award from the American Academy of Ophthalmology. Dr. Huang leads the Center for Ophthalmic Optics and Lasers and is a founder of GoCheck, the maker of the GoCheck Kids smartphone app that has screened over 1 million children for amblyopia risk factors.

Joyce Liao, M.D., Ph.D.

Joyce Liao, MD, PhD is Associate Professor of Ophthalmology and Neurology at Stanford. She is a clinician-scientist whose clinical interests include ischemic optic neuropathy, hypoxic ischemic injury, stroke, eye movement disorders and diplopia (among other).  As a scientist, she is dedicated to making basic discoveries in areas that include understanding and treating conditions that lead to retinal ganglion cell loss and irreversible thinning of the optic nerve, visual retraining due to stroke, and the mechanisms of anterior ischemic optic neuropathies. 

Liao received her undergraduate degree from Harvard University in Biochemical Sciences and her MD, PhD in Neuroscience from University of California San Francisco, where she also completed a Fellowship in Neuro-Ophthalmology. She serves as the Director of the Neuro-Ophthalmology Service and Neuro-Ophthalmology Fellowship as well as Co-Director of the Vision Research Training Program.

Prithvi Mruthyunjaya, M.D., M.H.S.

Prithvi Mruthyunjaya, MD MHS, is Associate Professor of Ophthalmology at Stanford University where he is a member of the Vitreoretinal Surgery Service and the Director of Ocular Oncology at the Byers Eye Institute. He cares for patients with conditions related to cancer of the eye in both adults and children--either benign, pre-cancerous, or eye cancer. He also manages complicated retinal diseases including retinal detachment, macular holes, epiretinal membranes, and diabetic eye disease. He specializes in developing collaborative research networks and training the next generation of vitreoretinal surgeons and his academic contributions were recognized by the Heed, AOS-Knapp and Ronald G Michels foundations the American Society of Retina Specialists with a Senior Honor Award. He was recently listed as one of the world’s 150 most innovative retinal specialists.

Mruthyunjaya was born in India and moved to Upstate New York at the age of 2. He completed his medical studies at Albany Medical College where he was elected to the Alpha Omega Alpha. At the Duke Eye Center in Durham, NC, he rose to chief resident and went on to complete a fellowships in Vitreoretinal Surgery. He followed this with a fellowship in Ocular Oncology at the Moorfields Eye Hosptial in London, UK.

Joseph Panarelli, M.D.

Joseph Panarelli, MD ​is an Associate Professor of Ophthalmology at the NYU School of Medicine who specializes in the treatment of adult and pediatric glaucoma. Dr. Panarelli is certified by the American Board of Ophthalmology, and he is a member of the American Glaucoma Society as well as the American Academy of Ophthalmology. He received his BS from Georgetown University’s McDonough School of Business in 2003 and his medical degree from the Georgetown University School of Medicine in 2007 where he was elected to the Alpha Omega Alpha honor medical society during his junior year.  He completed a residency in ophthalmology at the New York Eye and Ear Infirmary. He was awarded the William and Judith Turner Award for excellence in ophthalmologic training.  Following a year of fellowship training in glaucoma at the Bascom Palmer Eye Institute in Miami, he joined the faculty at Bascom Palmer for an additional year prior to returning to New York Eye and Ear as a member of the full-time faculty.  For 5 years at the New York Eye and Ear Infirmary, he was active in resident education, serving as the Associate Residency Program Director as well as Glaucoma Fellowship Director.

Dr. Panarelli recently transitioned to NYU where he serves as the Chief in the Division of Glaucoma Services and Director of the Glaucoma Fellowship. Dr. Panarelli is the recipient of several awards including the Mentoring for Advancement of Physician-Scientist Award from the American Glaucoma Society and was selected as a Castle Connolly Top Doctor in 2017 and 2018. He has published extensively in his field and is a principal investigator for numerous studies pertaining to the surgical management of glaucoma.

Vance Thompson, M.D.

Vance Thompson, MD is Professor of Ophthalmology at the Sanford University of South Dakota School of Medicine and the founder of Vance Thompson Vision in Sioux Falls, South Dakota, where he specializes in laser vision correction and advanced cataract surgery. Thompson leads a collaborative team of medical professionals in treating vision conditions using advanced technology and innovative techniques. A leader in clinical research, Thompson has played an important role in the discovery and development of the advanced technologies and techniques used in both laser and implant vision correction surgeries today. Serving as the medical monitor lead, or principal investigator, Dr. Thompson has led over 65 FDA-monitored clinical trials on the subjects and has published numerous papers and book chapters on his findings. In addition, Dr. Thompson co-authored a textbook titled Refractive Surgery.

Thompson received his bachelor’s and medical degree at the University of South Dakota School of Medicine. He performed his Ophthalmology Residency at the University of Missouri and went on to complete a fellowship in Corneal and Refractive Surgery at the Hunkeler Eye Clinic in Overland Park, Kansas. Thompson lectures extensively throughout the world highlighting meetings such as the American Academy of Ophthalmology and the Association for Cataract and Refractive Surgery conferences.